liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors
Karolinska Inst, Sweden.
Karolinska Inst, Sweden.
Karolinska Inst, Sweden; Karolinska Univ Hosp Solna, Sweden.
Karolinska Inst, Sweden; SciLifeLab, Sweden.
Show others and affiliations
2019 (English)In: Oncogene, ISSN 0950-9232, E-ISSN 1476-5594, Vol. 38, no 43, p. 6881-6897Article in journal (Refereed) Published
Abstract [en]

Patients with small intestinal neuroendocrine tumors (SI-NETs) frequently develop spread disease; however, the underlying molecular mechanisms of disease progression are not known and effective preventive treatment strategies are lacking. Here, protein expression profiling was performed by HiRIEF-LC-MS in 14 primary SI-NETs from patients with and without liver metastases detected at the time of surgery and initial treatment. Among differentially expressed proteins, overexpression of the ubiquitin-like protein NEDD8 was identified in samples from patients with liver metastasis. Further, NEDD8 correlation analysis indicated co-expression with RBX1, a key component in cullin-RING ubiquitin ligases (CRLs). In vitro inhibition of neddylation with the therapeutic agent pevonedistat (MLN4924) resulted in a dramatic decrease of proliferation in SI-NET cell lines. Subsequent mass spectrometry-based proteomics analysis of pevonedistat effects and effects of the proteasome inhibitor bortezomib revealed stabilization of multiple targets of CRLs including p27, an established tumor suppressor in SI-NET. Silencing of NEDD8 and RBX1 using siRNA resulted in a stabilization of p27, suggesting that the cellular levels of NEDD8 and RBX1 affect CRL activity. Inhibition of CRL activity, by either NEDD8/RBX1 silencing or pevonedistat treatment of cells resulted in induction of apoptosis that could be partially rescued by siRNA-based silencing of p27. Differential expression of both p27 and NEDD8 was confirmed in a second cohort of SI-NET using immunohistochemistry. Collectively, these findings suggest a role for CRLs and the ubiquitin proteasome system in suppression of p27 in SI-NET, and inhibition of neddylation as a putative therapeutic strategy in SI-NET.

Place, publisher, year, edition, pages
NATURE PUBLISHING GROUP , 2019. Vol. 38, no 43, p. 6881-6897
National Category
Cell and Molecular Biology
Identifiers
URN: urn:nbn:se:liu:diva-161848DOI: 10.1038/s41388-019-0938-8ISI: 000492728000001PubMedID: 31406256OAI: oai:DiVA.org:liu-161848DiVA, id: diva2:1370883
Note

Funding Agencies|NovartisNovartis; Swedish Research CouncilSwedish Research Council; Swedish Cancer SocietySwedish Cancer Society; Cancer Society in Stockholm; Gustav V Jubilee Foundation; Stockholm County CouncilStockholm County Council; Karolinska InstitutetKarolinska Institutet

Available from: 2019-11-18 Created: 2019-11-18 Last updated: 2019-11-18

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Kharaziha, Pedram
By organisation
Division of Cell BiologyFaculty of Medicine and Health SciencesClinical genetics
In the same journal
Oncogene
Cell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf